
Atinum Partners
Description
Atinum Partners, operating as Atinum Investment, is a prominent venture capital firm headquartered in Seoul, South Korea. Established in 1988, the firm has cultivated a strong reputation for its strategic investments in growth-stage companies. Atinum Investment is a significant player in the South Korean startup ecosystem, providing essential capital and strategic support to help innovative businesses achieve their scaling objectives across various high-potential industries.
The firm's investment strategy primarily focuses on growth-stage startups within the IT, biotech, and healthcare sectors, with additional interests in new materials and components. Atinum Investment is recognized for its substantial capital commitments, typically deploying first cheques that range from approximately $2.5 million to $8.4 million. This approach allows them to secure meaningful equity stakes and provide the robust financial backing necessary for companies transitioning from initial development to significant market expansion and operational maturity.
Atinum Investment has built an impressive portfolio, having invested in over 200 companies since its founding, and has led 39 funding rounds, according to Crunchbase. The firm also boasts a strong track record of successful exits, with 30 reported exits, underscoring its capability to generate substantial returns for its limited partners. In 2021, Atinum Investment notably closed a new fund totaling 100 billion Korean Won (approximately $84 million USD), further enhancing its capacity to support large-scale growth initiatives and reinforce its position as a leading investor in the region.
Investor Profile
Atinum Partners has backed more than 49 startups, with 13 new investments in the last 12 months alone. The firm has led 11 rounds, about 22% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in South Korea, United States, Singapore.
- Strong thematic focus on Artificial Intelligence (AI), Software, Biotechnology.
- Led 5 rounds in the past year.
- Typical check size: $2.5M – $8.4M.
Stage Focus
- Series B (27%)
- Series A (27%)
- Series C (16%)
- Seed (14%)
- Series D (8%)
- Series E (4%)
- Series Unknown (4%)
Country Focus
- South Korea (49%)
- United States (31%)
- Singapore (12%)
- Israel (4%)
- Japan (4%)
Industry Focus
- Artificial Intelligence (Ai)
- Software
- Biotechnology
- Enterprise Software
- Information Technology
- Finance
- Financial Services
- Health Care
- Machine Learning
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.